<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Novartis adds joint supplement for dogs to its range </title><link>/b/veterinary-nursing-news/posts/146470</link><description> Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland. 
 Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>